SCHEMBL1779174

SCHEMBL1779174

CCOC(=O)n1nc(NC(=O)c2ccccc2NC(=O)c2cnoc2C)c2cc(C(=O)O)sc21

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
CSF1R P07333 1/20 0.38
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 3/20 0.37
GAA P10253 1/20 0.37
TP53 P04637 4/20 0.36
RXFP1 Q9HBX9 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 4/20 0.36
TSHR P16473 4/20 0.36
POLB P06746 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.36
KDM4E B2RXH2 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4592874 0.91 RAB9A (0.41) RAB9ANPC1CSF1RALDH1A1TP53
SCHEMBL1780244 0.91 HSD17B10 (0.38) RAB9ANPC1CSF1RALDH1A1HSD17B10
SCHEMBL1779652 0.89 RXFP1 (0.36) RAB9ANPC1CSF1RALDH1A1HSD17B10
SCHEMBL4592913 0.88 ITGA4 (0.34) RAB9ANPC1CSF1RALDH1A1HSD17B10
SCHEMBL1777881 0.86 HSD17B10 (0.35) RAB9ANPC1CSF1RALDH1A1HSD17B10
SCHEMBL1779425 0.85 MAPK1 (0.46) RAB9ANPC1ALDH1A1HSD17B10GAA
SCHEMBL1780614 0.85 RAF1 (0.42) CSF1R
SCHEMBL1778607 0.85 ALDH1A1 (0.38) RAB9ANPC1ALDH1A1HSD17B10GAA
SCHEMBL1779165 0.84 KDM4E (0.38) RAB9AALDH1A1HSD17B10GAATP53
SCHEMBL1779798 0.83 KDR (0.40) RAB9ANPC1ALDH1A1HSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904503-B1 1H-THIENO[2,3-C]-PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2013-11-06 EP disclosed
US-7943654-B2 1H-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-17 US disclosed
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors CCNH, PDK1, MAP3K5 RAB9A 2971/4885NPC1 2677/4885CSF1R 3241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.